High Prevalence of Chronic Disorders and R&D in Stem Cells to Augment Growth of Stem Cells Market

Stem cells are basically cells with the capacity to turn into different kinds of cells. These cells are used in the manufacture of blood, skin, heart, lungs, pancreas and a variety of other organs. They play an important role in organ transplants, tissue engineering and in the therapy of Parkinson's disease.

The PDF for the study can be requested using the following link: https://www.coherentmarketinsights.com/insight/request-pdf/4222

In fact, stem cells harvested from the adult marrow have already helped treat some of these diseases. Scientists have succeeded in transplanting adult stem cells from the anogenital area of the male reproductive organ to patients with chronic diseases like Parkinson's disease, a disease that affects both the nervous and the cardiac systems.

This procedure has proven to be very effective in treating the disease since it stimulates the production of the living cells in the diseased area. Since adult stem cells could help treat Parkinson's disease, the researchers tested their idea in animals and succeeded. Stem cells from the adult bone marrow have also shown great potential in treating diseases like arthritis, psoriasis and multiple sclerosis.

Market Dynamics

High prevalence of chronic disorders is expected to propel growth of the global stem cells market. For instance, according to the study, ‘Prevalence of Parkinson’s disease (PD) across North America”, published in July 2018 in the journal Nature, the number of people suffering from PD is expected to reach 930,000 in 2020 and 1,238,000 in 2030.

R&D in stem cells is expected to offer lucrative growth opportunities for players in the global stem cells market. For instance, in December 2020, researchers from the Wake Forest Institute for Regenerative Medicine demonstrated that stem cells found in amniotic fluid meet an essential test increasing their likelihood of becoming specialized
cell types.

Competitive Analysis

Major players operating in the global stem cells market include, Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Bioheart Inc., Lineage Cell Therapeutics., BrainStorm Cell Therapeutics, Inc., California Stem Cell Inc., Global Stem Cells Group, Celgene Corporation, Takara Bio Europe AB, Cellular Engineering Technologies, Cytori Therapeutics Inc., Osiris Therapeutics, and STEMCELL Technologies Inc.

Major players operating in the global stem cells market are focused on adopting M&A strategies to enhance their market share. For instance, in October 2020, Global Stem Cells Group signed an agreement with Bioscience Cell Factory, a Dubai-based healthcare company, which will allow GSCG to act as their representatives operating in both the Middle East and Latin America.

Buy Now with Discount for Premium Report : https://www.coherentmarketinsights.com/promo/buynow/4222

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.